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Abstract
Background
Monitoring adherence to national recommendations for annual chlamydia screening of fe-
male adolescents and young adult women is important for targeting quality improvement in-
terventions to improve low screening rates. However, accurate measurement of rates may
vary depending on the data source used to determine eligible sexually-active women.
Methods
The 2001–2004 NHANES data linked with Medicaid administrative data by respondent’s
unique identifier, the 2011–2012 NHANES data, and the 2004 and 2010 Medicaid data
were used in this cross-sectional analysis. We defined self-reported sexual activity by self-
reported sexual behaviors, claim-identified sexual activity by reproductive-related claims
among women who had one healthcare claim, HEDIS-defined sexual activity by repro-
ductive-related claims among women who were enrolled in Medicaid for330 days and
had one healthcare claim, and chlamydia tests by claims submitted in the 12 months prior
to the survey interview.
Results
Of Medicaid women aged 18–25 years, 91.5% self-reported to be sexually-active. Of self-
reported sexually-active women aged 18–25 years, 92.0% had one healthcare claim in
the 12 months prior to the survey interview; of this subpopulation, only 58.8% were enrolled
in Medicaid for 330 days in the 12 months prior to the survey interview; of this further sub-
population, 74.1% had healthcare claims identifying them as sexually-active in the 12
months prior to the survey interview. Of HEDIS-defined sexually-active women, 42.4% had
chlamydia testing.
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Conclusion
Our study suggests that the number of sexually-active women aged 18–25 years used as
the denominator in the chlamydia testing measure could be significantly different, depend-
ing upon the definition applied and the data used. Our data highlight the limited representa-
tiveness of Medicaid population in the current HEDIS measure on chlamydia testing when a
high proportion of women who were enrolled in Medicaid for <330 days had been excluded
from the measure. The interventions that can improve the proportion of women who were
enrolled in Medicaid for 330 days among all young Medicaid women are needed not only
for improving health care services, but also for measuring quality of healthcare.
Introduction
Chlamydial infection is the most commonly reported infectious disease, and its prevalence is
the highest in women aged 25 years in the United States.[1] Because a high proportion of in-
fected women are asymptomatic, healthcare providers frequently rely on screening to detect
chlamydial infections. The Centers for Disease Control and Prevention (CDC) has recom-
mended annual screening of all sexually-active women aged 25 years, or older women with
risk factors (e.g., those who have a new sex partner or multiple sex partners).[2] Many other or-
ganizations have similar recommendations.[3–6] Sexual activity is normally identified by self-
reported sexual behaviors, medical records, or healthcare claims.[7–9]
Efforts and activities to monitor chlamydia testing for sexually-active young women have
been conducted in the United States. Using a national survey, chlamydia testing rates were esti-
mated to be 43% in 2002, and 38% in 2006–2008 for all sexually-active U.S. women aged 15–25
years.[10,11] In 1999, the National Committee for Quality Assurance (NCQA), an indepen-
dent, nonprofit organization that assesses and reports on the quality of care delivered by man-
aged care organizations, instituted a performance measure for annual screening of sexually-
active women aged 15–25 years for chlamydia into the performance measurement system
known as the Healthcare Effectiveness Data and Information Set (HEDIS).[12] The HEDIS
measure for chlamydia testing represents the continuously-enrolled and sexually-active
women aged 16–25 years who were tested for chlamydia in the prior 12 months. Sexually-ac-
tive women in the HEDIS measure were identified as women who had any reproductive-related
medical or pharmacy claims. Continuously-enrolled women were those who had no more than
a one-month gap if they were insured in Medicaid HMO plans. Monitoring of chlamydia test-
ing trends based on the HEDIS data has shown consistent increases since the implementation
in 2001, from 23.1% to 45.1% in 2012 among HMO commercial plans; and from 40.4% in 2001
to 57.1% in 2012 among Medicaid HMO plans.[13]
The aim of the current HEDIS measure on chlamydia testing is to minimize the number of
false positives identified as part of the denominator population, and to make this denominator
more closely reflect the at-risk population for chlamydial infection.[8] If self-reported sexual
activity is known and considered to be the best indicator of whether a person is sexually-active,
it can be used to identify four errors in the way of identifying sexual activity used in the HEDIS
measure. One group of women will be erroneously included, and three other groups of women
will be erroneously excluded. The inclusion group is the self-reported non-sexually-active
women who were identified to be sexually-active by claims. The three exclusion groups are (1)
the self-reported sexually-active women who had no medical or drug claims in the prior 12
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months, (2) the self-reported sexually-active women who had a one-month gap in Medicaid
coverage during a measurement year, and (3) the self-reported sexually-active women who had
medical or drug claims, but these claims were not related to reproductive healthcare. Because
these exclusions might result in an overestimated chlamydia testing rate (due to an artificially
low denominator), many researchers have concerned about the measurement of sexual activity
since this HEDIS measure was first used in 2000.[9,14–16] One previous study compared sexu-
al activity measured by self-reported behavior using a national representative survey with that
measured by healthcare claims using a large commercial claims database.[9] However, persons
in one database could not be linked to persons in another database in that study. A recent
study conducted in a commercial managed care organization is the only study so far that com-
pared women’s sexual activity measured by self-reported behaviors to that measured by health-
care claims.[17] The study showed that of women aged 18–25 years who self-reported being
sexually-active and who had no one-month gap in insurance coverage, approximately 85%
were classified as sexually-active by the HEDIS measure; of women aged 18–25 years who self-
reported being non-sexually-active, approximately 64% were classified as non-sexually-active
by the HEDIS measure. To our knowledge, there are no nationally representative studies that
have compared sexual activity measured by self-reported behaviors with that measured by
healthcare claims for each person.
Using nationally representative survey data, linked with Medicaid administrative data, we
were able to estimate the proportion of Medicaid women who were identified as sexually-active
by self-reported behaviors and by healthcare claims, and to estimate chlamydia testing rates.
The aim of this study was to understand sexual activity measures from different data sources
and their impact on chlamydia testing rates when these measures were used as the denomina-
tor. In the future it should provide information for interventions to better monitor chlamydia
testing for the young population in the United States.
Methods
NHANES Data
The National Health and Nutrition Examination Survey (NHANES), conducted by the Nation-
al Center for Health Statistics (NCHS), is designed to assess the health and nutritional status of
adults and children in the United States. The NHANES is unique in that it combines interviews
and physical examinations. The interview includes demographic, socioeconomic, dietary, and
health-related questions. Audio computer-assisted self-interviewing is used to ask sensitive
questions, such as sexual behaviors, during the interview. The examination component consists
of medical, dental, and physiological measurements, as well as laboratory tests administered by
highly trained medical personnel. The sampling selection of the NHANES involves complex
and multistage probability sampling design. A nationally representative sample of about 5,000
persons is surveyed each year for the civilian and non-institutionalized U.S. population. Re-
sponse rates were 80% in 2001–2002 and 76% in 2003–2004 for women with both interviews
and physical examinations.
MAX Data
The Centers for Medicare & Medicaid Services (CMS) has created Medicaid Analytic eXtract
(MAX) administrative data, which include enrollment and utilization data for persons from
low income families who either enrolled in Medicaid or in the Children’s Health Insurance
Program (CHIP) in all 50 states and the District of Columbia, for research and policy. The
MAX enrollment file, known as the Person Summary (PS) file, includes enrollee-level informa-
tion on enrollment status for each month, eligibility criteria for Medicaid or CHIP, and type of
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insurance plan (fee-for-service, or managed care). The MAX utilization data, which include in-
patient files, prescription drugs files, long-term care files, and other services files, contain ser-
vice utilization and date of services. The MAX PS files are person-level files, and the MAX
utilization files are service-level files.
One of the ways to access the MAX data is through the CMS Virtual Research Data Center
(VRDC). An Inter-Agency Agreement (IAA) for access to MAX data through VRDC was es-
tablished between CDC and CMS in July 2013. Under the agreement, CDC researchers need to
sign a data use agreement and submit their proposals to the CMS Privacy Board, which serves
to ensure that patients’ privacy is protected and the need for identifiable data is justified. After
the CMS Privacy Board approves the request, CDC researchers have access to a subset of the
MAX data, according to the minimum data necessary rule.
Data Linkage
NCHS and CMS have also created a set of analytic data files linking NHANES data to MAX
data by NHANES respondent’s unique identifier.[18] The unique identifier includes Social Se-
curity number (SSN) and date of birth. The linked databases provide unique opportunities for
research and policy analysis to study changes in health status, healthcare utilization, and cost
in low income families with children, young adults, elderly adults, and disabled U.S. popula-
tions. CMS had provided NCHS with the MAX data for 1999 through 2007 for all successfully
matched NHANES respondents. For example, the 2002 NHANES data with respondents who
reported being enrolled in Medicaid in 2002 were matched with the MAX data by each year
from 1999 through 2007, although many of these enrollees might not be enrolled in Medicaid
for all years during 1999–2007. This linked dataset provides the opportunity to examine all
healthcare utilization for the NHANES respondents who were matched with MAX data in the
years they were enrolled in Medicaid during 1999–2007.
The linked analytic data with de-identified human participants generated from the linked
data by NCHS are only accessible through the Research Data Center (RDC) at CDC after a re-
search proposal is submitted and approved by the CDC review committee for purposes con-
cerning potential disclosure risk.
Data Used and Study Population
The 2001–2004 NHANES data were the most recent NHANES data available to be linked to
the MAX data. The linked 2001–2004 NHANES-MAX data (2001–2004 NHANES data linked
to 2000–2004 MAX data) were primarily used in this study. The study population included the
2001–2004 NHANES respondents who were women aged 18–25 years at interview, and
matched to women in the 2000–2004 MAX data. The reason for using 2000–2004 MAX data
rather than 2001–2004 MAX data was that enrollment and claims information in the 12
months prior to the survey interview was required for women surveyed in the 2001–2004
NHANES data. The reason that the study population included only women aged 18–25 years
rather than women aged 15–25 years, used in the HEDIS measure for chlamydia testing, was
that women aged18 years in 2001–2004 NHANES data had been asked the number of their
sexual partners during the past 12-month period. Women aged<18 years in the 2001–2004
NHANES data were not asked about their sexual behaviors in the past 12 months.
Measures on Sexual Activity
Self-reported sexual activity. Of Medicaid women aged 18–25 years, their self-reported
sexual activity was measured by two questions in the NHANES data, “Have you ever had sexual
intercourse?” and, “In the past 12 months, with how many men have you had sexual
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intercourse?”Women aged 18–25 years were classified as sexually-active if they had sexual in-
tercourse with one man in the past 12 months, and classified as non- sexually-active if they had
never had sexual intercourse, or had no sexual intercourse in the past 12 months.
Claim-identified sexual activity. The claim-identified sexual activity was measured by
claims for reproductive-related medical or prescription services among women who had one
healthcare claim in the 12 months prior to their survey interview in the MAX data. We used
the month of the survey interview as the index month, and considered the index month and 11
months prior to the index month as the 12 months prior to the survey interview. Reproductive
health services were identified by their healthcare claims, using several standard coding sys-
tems—the International Classification of Disease, Ninth Revision, Clinical Modification (ICD-
9-CM), the Physicians’ Current Procedural Terminology, 2012 (CPT 2012), National Drug
Code Directory (NDC), and inpatient UB-92 revenue code (UB_92).[12] Reproductive-related
claims were identified if women had, within the 12 months prior to the survey interview,
healthcare claims that were associated with any of the following five reproductive health cate-
gories: 1) a cervical cancer screening service or pelvic examination, 2) a contraceptive service,
3) a pregnancy-related service, 4) an STD-related service, or 5) an infertility service. Women
were classified as ineligible if they had no healthcare claim, or as eligible if they had healthcare
claims in the 12 months prior to their survey interview. Of eligible women, they were classified
as non-sexually-active if they had no reproductive-related claim, or as sexually-active if they
had reproductive-related claims in the 12 months prior to their survey interview.
HEDIS-defined sexual activity. To be comparable to the denominator of the HEDIS mea-
sure on chlamydia testing (i.e., continuously enrolled without a gap of> one-month in Medic-
aid, and had one healthcare claim in the measurement year), HEDIS-defined sexual activity
was measured by claims for reproductive-related medical or prescription services among
women who hadone healthcare claim, and who were enrolled in Medicaid for330 days in
the 12 months prior to their survey interview. Women were classified as ineligible if they had
no healthcare claim, or they were enrolled in Medicaid for<330 days, or as eligible if they had
healthcare claims and they were enrolled in Medicaid for330 days in the 12 months prior to
their survey interview. Of eligible women, they were classified as non-sexually-active if they
had no reproductive-related claim, or as sexually-active if they had reproductive-related claims
in the 12 months prior to their survey interview.
Chlamydia Testing and Additional Data Used
Chlamydia tests were identified by CPT codes if the tests were performed within the 12 months
prior to the survey interview.[12]
Because the linked 2001–2004 NHANES-MAX data are more than 10 years from present,
we also used the more recent data to confirm that the key findings from the linked 2001–2004
NHANES-MAX data are still relevant to the current healthcare environment. We used the
2011–2012 NHANES data, which are the most recent NHANES data available to the authors,
and have not been linked to the MAX data by CMS and NCHS yet, to compare the proportion
of Medicaid women aged 18–25 years who self-reported to be sexually-active between the
linked 2001–2004 NHANES-MAX data and the 2011–2012 NHANES data. Similarly, we used
the 2004 MAX data and the 2010 MAX data that are the most recent MAX data available to the
authors through VRDC to compare the proportion of women aged 18–25 years who were en-
rolled in Medicaid for330 days within the 12 months prior to the survey interview in the
linked 2001–2004 NHANES-MAX data to that of women aged 18–25 years who were enrolled
in Medicaid for330 days in 2004, and in 2010, using the 2004 MAX data and the 2010 MAX
data, respectively.
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Because the 2004 and 2010 MAX data that the authors have access to through VRDC in-
clude only de-identified human participants, using 2004 and 2010 MAX data does not require
a CDC institutional review board review.
Statistical Analyses
Statistical analyses were conducted using the SAS System for Windows (release 9.3; SAS Insti-
tute Inc., Cary, NC) and SUDAAN (release 10.0; Research Triangle Institute, Research Triangle
Park, NC). Most estimates incorporated the sample weight, and variance calculations ac-
counted for the complex sample design of the NHANES data. All significance tests to compare
weighted proportions were evaluated using a Chi-square test with two-sided p-value<0.05 as
the level of statistical significance. Estimates with a sample size less than five counts were sup-
pressed according to the NCHS guide. To demonstrate the number of days in Medicaid enroll-
ment having impact on the proportion of women who had one healthcare claim or on
chlamydia testing rate, we also estimated proportions of women who had one healthcare
claim, and chlamydia testing rates between women with330 days of enrollment and those
with<210 days of enrollment. A simple analysis was conducted using SAS for the 2004 MAX
data and the 2010 MAX data, because all Medicaid women aged 18–25 years–rather than a
sample of them–were included.
Results
Of annual 3.3 million Medicaid women aged 18–25 years weighted by a sample of 338 women
in the linked 2001–2004 NHANES-MAX data, 91.5% (3.1 million women) self-reported to be
sexually-active (Table 1). Self-reported sexual activity was not significantly associated with age,
marital status, race/ethnicity, and the days of enrollment in the past 12 months. The compari-
son of three measures on sexual activity is presented in Table 2. Of 3.0 million and 1.8 million
Medicaid women aged 18–25 years who were eligible for the claim-identified and the HEDIS-
defined sexual activity measure, 73.3% and 69.8% were classified as sexually-active, respective-
ly. Of 3.1 million women who self-reported to be sexually-active, 45.9% were ineligible for the
Table 1. Demographics and enrollment of linked Medicaid women aged 18–25 years (N = 338), 2001–
2004.
National Medicaid population Self-reported sexual activity % (standard error)
Age group (year)
18–19 757,522 88.0 (3.6)
20–25 2,578,380 92.5 (3.3)
Race/ethnicity
Non-Hispanic white 1,455,297 90.9 (4.8)
Non-Hispanic black 1,102,390 93.7 (2.8)
Hispanic or other 778,215 89.3 (5.2)
Marital status
Never married 2,001,541 87.9 (3.1)
Other 1,334,361 96.4 (3.6)
Days of enrollment
1–209 757,534 96.2 (2.3)
210–329 667,715 93.5 (2.7)
330 1,910,653 88.8 (4.0)
Total 3,335,902 91.5 (2.7)
doi:10.1371/journal.pone.0122927.t001
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HEDIS measure. Of HEDIS-defined non-sexually-active women aged 18–25, 77.5% self-re-
ported to be sexually-active; of self-reported non-sexually-active women aged 18–25 years,
18.8% were HEDIS-defined sexually-active.
Of 3.1 million women who self-reported to be sexually-active, 40.1% were sexually-active by
the HEDIS-defined measure (Fig 1). More specifically, of these 3.1 million women, 92.0%
had one healthcare claim; of the self-reported sexually-active women who had one health-
care claim, 58.8% had been enrolled in Medicaid for330 days in the 12 months prior to the
survey interview; of these self-reported sexually-active women with330 days of Medicaid en-
rollment, 74.1% had healthcare claims to indicate that they were sexually-active.
Using the HEDIS measure, 42.4% of the HEDIS-defined sexually-active women aged 18–25
years had chlamydia testing (Table 3). Chlamydia testing rate was not significantly associated
with age, marital status, and race/ethnicity among the HEDIS-defined sexually-active women.
Of self-reported sexually-active women aged 18–25 years, 30.7% (SE = 5.0) had chlamydia test-
ing. Of self-reported sexually-active women aged 18–25 years with330 days of Medicaid cov-
erage who had one healthcare claim, 32.6% (SE = 8.3%) had chlamydia testing. Of women
aged 18–25 years who were identified to be sexually-active by both the self-reported measure
and by the HEDIS-defined measure, 44.0% (SE = 9.7%) had chlamydia testing.
Of self-reported sexually-active women aged 18–25 years, women who had enrolled in Med-
icaid for330 days were more likely to have one healthcare claim than those who had en-
rolled for< 210 days (95.5% SE = 2.2% versus 81.0% SE = 7.6%). Of claim-identified sexually-
active women aged 18–25 years, the chlamydial testing rate decreased from 42.4% (SE = 9.7)
Table 2. Agreement of self-reported versus claim-identified versus HEDIS-defined sexual activity among annual 3.3 million Medicaid women aged
18–25 Years (N = 338), 2001–2004.
Self-reported Claim-identiﬁed HEDIS-deﬁned
Yes N (%) No N (%) Yes N (%) No N (%) Ineligible N
(%)
Yes N (%) No N (%) Ineligible N
(%)
Self-reported
Yes (N = 3,050,918) 3,050,918
(100)
0 (0) 2,166,885
(71.0)
639,616
(21.0)
244,417 (8.0) 1,221,935
(40.1)
427,381
(14.0)
1,401,602
(45.9)
No (N = 284,984) 0 (0) 284,984
(100)
112,542
(39.5)†
172,442
(60.5)
† 53,657 (18.8) 123,862
(43.5)
107,465 (37.7)
Claim-identiﬁed
Yes (N = 2,232,920) 2,166,885
(97.0)
66,035 (3.0) 2,232,920
(100)
0 (0) 0 (0) 1,275,592
(57.1)
0 (0) 957,328 (42.9)
No (N = 812,059) 639,616 (78.8) 172,443
(21.2)
0(0) 812,059
(100)
0 (0) 0 (0) 551,242
(67.9)
260,817 (32.1)
Ineligible
(N = 290,923)
290,923
(100)‡
‡ 0(0) 0(0) 290,923 (100) 0 (0) 0 (0) 290,923(100)
HEDIS-deﬁned
Yes (N = 1,275,592) 1,221,935
(95.8)
53,657 (4.2) 1,275,592
(100)
0 (0) 0 (0) 1,275,592
(100)
0 (0) 0 (0)
No (N = 551,243) 427,382 (77.5) 123,861
(22.5)
0 (0) 551,243
(100)
0 (0) 0 (0) 551,243
(100)
0 (0)
Ineligible
(N = 1,509,067)
1,401,602
(92.9)
107,465
(7.1)
957,328 (63.4) 260,817
(17.3)
290,922
(19.3)
0 (0) 0 (0) 1,509,067
(100)
† Estimate was combined from ‘Yes’ category and ‘Ineligible’ category.
‡ Estimate was combined from ‘Yes’ category and ‘No’ category.
doi:10.1371/journal.pone.0122927.t002
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among women with330 days of enrollment to 24.9% (SE = 7.1%) among women with<210
days of enrollment.
Of Medicaid women aged 18–25 years, 57.3% were enrolled in Medicaid for330 days in
the linked 2001–2004 NHANES-MAX data versus 50.9% in the 2004 MAX data, versus 53.9%
in the 2010 MAX data. Of Medicaid women aged 18–25 years, 91.5% self-reported to be sexual-
ly-active in the linked 2001–2004 NHANES-MAX data, versus 92.9% in the 2011–2012
NHANES data.
Fig 1. Steps were used in identifying the number of HEDIS-defined sexually-active women among
self-reported sexually-active women.
doi:10.1371/journal.pone.0122927.g001
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Discussion
To the best of our knowledge, this is the first nationally representative study to use both self-re-
ported survey data and healthcare utilization data to research women’s sexual activity. Com-
paring self-reported survey data to healthcare utilization data, our findings showed that many
of the self-reported sexually-active women aged 18–25 years had no healthcare utilization re-
cord, were not continuously enrolled in Medicaid, or had no reproductive-related healthcare
utilization in the 12 months prior to the survey interview. Because many of self-reported sexu-
ally-active women were ineligible for HEDIS-defined measure during 2001–2004, as a result,
only about 40% of self-reported sexually-active women were the HEDIS-defined sexually-ac-
tive women in the Medicaid population, a denominator in the HEDIS measure on chlamydia
testing. With consistent and low proportions of Medicaid women aged 18–25 years who were
enrolled for330 days in Medicaid, 50.9% in the 2004 MAX data versus 53.9% in the 2010
MAX data versus 57.3% in the linked 2001–2004 NHANES-MAX data for Medicaid women,
our study highlighted that the denominator used in the HEDIS measure on chlamydia testing
had limited representation of Medicaid women aged 18–25 years under the current
healthcare environment.
There is a limitation of measuring quality of healthcare in Medicaid when a high proportion
of women were excluded from the measure. Several administrative changes for improving con-
tinuity of Medicaid coverage, such as changes in renewal policy or extended eligibility criteria
to young adults, have been suggested in previous studies.[19,20] With more and more states
implementing these policies, Medicaid’s continuity of coverage will improve. Consequently,
healthcare quality measures will be more representative, because most eligible Medicaid people
will be included in the HEDIS measures.
Our chlamydia testing rates also varied according to the denominator measures used. The
testing rate was approximately 31% for all self-reported sexually-active women, but 44%
among women who were identified as sexually-active by both the self-reported measure and by
the HEDIS-defined measure. Our HEDIS measure on chlamydia testing rate was similar to
that reported using NCQA data.[21] Our findings suggest that the measure and the data
sources need to be stated clearly when chlamydia testing rates are reported. Our findings recon-
firmed that for results to be similar to the HEDIS measure on chlamydia testing, women aged
15–25 years should be limited to those who were continuously enrolled in health plans
for 330 days, and those who had reproductive-related claims during the measurement year.
Table 3. HEDIS-defined sexual activity and chlamydia testing rates among women aged 18–25 years who were eligible for the HEDISmeasure
(N = 172), 2001–2004.
Population HEDIS-deﬁned sexual activity % (standard error) Chlamydia testing rate% (standard error)
Age groups (years)
18–19 355,093 58.8 (8.8) 49.1 (10.5)
20–25 1,471,742 72.5 (6.3) 41.1 (10.5)
Race/ethnicity
Non-Hispanic white 682,616 67.8 (10.3) 26.1 (11.4)
Non-Hispanic black 714,950 63.9 (10.0) 45.0 (8.2)
Hispanic or other 429,269 83.0 (8.0) 60.3 (14.2)
Marital status
Never married 1,094,297 63.9 (7.9) 29.9 (8.0)
Other 732,538 78.7 (7.5) 57.5 (12.6)
Total 1,826,835 69.8 (5.7) 42.4 (9.7)
doi:10.1371/journal.pone.0122927.t003
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The results of this study, plus the results from a recent related study, can provide informa-
tion to better understand on issues related to the measures for sexual activity.[17] Several esti-
mates from this study were within a reasonable range compared to the recent related study. For
example, the proportion of women who were HEDIS-defined sexually-active among self-re-
ported sexually-active women ranged from 74% in this study to 85% in the recent related
study; the chlamydia testing rate ranged from 42% in this study to 40% in the recent related
study. In addition, many associations related to sexual activity were similar between these two
studies. Although there are several differences related to study design between these two stud-
ies, such as years of the data used, Medicaid patients versus privately-insured patients, the na-
tionally representative data versus health plan data, the use of audio computer-assisted self-
interviewing versus the mail survey for confidentiality concerns, and a high response rate in
this study versus a low response rate in the recent related study, the two studies are comple-
mentary to each other. The unique contributions of these two studies are that our study high-
lights that the denominator used in the current HEDIS measure on chlamydia testing has
limited representation of Medicaid women, mainly due to insurance coverage, and the other
study showed that for women aged 18–25 years who self-reported non-sexually-active, approx-
imately 64% were classified as non-sexually-active by the HEDIS measure.
This study had a number of strengths. The NHANES data had a high response rate. It col-
lected valuable, sensitive data using audio computer-assisted self-interviewing to reduce partic-
ipant’s confidentiality concerns. The NHANES data provided national estimates of sexual
activity for Medicaid women. The estimates of sexual activity in the NHANES data were con-
sistent from 2001 to 2012 in this study. The linked NHANES-MAX data offered valuable infor-
mation for public health research. Self-reported sexual behaviors are much better than medical
records or healthcare claims to identify sexual activity, while healthcare claims may be much
better than self-reports to identify the procedure of chlamydia testing. There were, however,
several limitations in this study. First, the sample used represented only the Medicaid popula-
tion, rather than the general population. Second, our study excluded women aged<18 years
due to lack of self-reported sexual behaviors. Estimates among women aged 15–17 years may
differ from the ones presented in this study. Third, with a limited sample size for non-sexually-
active women classified by the self-reported measure, we could not do any further analysis by
age, race/ethnicity, or marital status. Fourth, sexually-active women aged 18–25 years and chla-
mydia testing rate might be underestimated, because 17% of procedure codes were under other
coding systems that could not be used to correctly identify sexuality or chlamydia testing in the
MAX data. Fifth, although our data showed that several key findings from the linked 2001–
2004 NHANES-MAX data are relevant to the current healthcare environment, the linked data
are more than 10 years from present. Finally, some women might not have been identified as
sexually-active, or having chlamydia testing, if they obtained out-of-plan care for their repro-
ductive-related service, and chlamydia testing that did not generate claims in the MAX data.
Our study suggests that the number of sexually-active women aged 18–25 years used as a
denominator in chlamydia testing could be significantly different, depending on the measures
applied and the data used. Therefore, when a chlamydia testing rate is reported, it is necessary
to describe clearly the measure and data sources used. Although the HEDIS measure provides
a consistent measure with which to track trends over time, our study highlighted key areas
where the HEDIS measure is suboptimal. Our data especially highlighted the limited represen-
tativeness of Medicaid population in measuring quality of healthcare when a high proportion
of Medicaid population is enrolled in Medicaid for<330 days.
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